Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Rachel Hazazi"'
Autor:
Amal Waked, Shlomo Birkenfeld, Z. Samuel, Yaron Niv, Rachel Hazazi, Alexander Vilkin, Eran Maoz, Moshe Leshno, Paul Rozen, Zohar Levi
Publikováno v:
Alimentary Pharmacology & Therapeutics. 31:523-533
Aliment Pharmacol Ther 31, 523–533 Summary Background Common reasons for elective screening and surveillance colonoscopy, at predetermined intervals, are family or personal history of colorectal cancer (CRC) or advanced adenoma (AAP). Quantified, h
Autor:
Gerald Fraser, Ofer Benjaminov, R. Krongrad, Yaron Niv, O. B. Tal, Rachel Hazazi, Zohar Levi, Abigail Fraser, A. Choen, J. Meyerovitch
Publikováno v:
Alimentary Pharmacology & Therapeutics. 30:1128-1136
Inflammatory bowel disease (IBD) patients undergo multiple radiological evaluations.To estimate total and abdominal radiation exposure from diagnostic X-ray investigations in IBD patients and the associated risk factors.Patients with Crohn's disease
Autor:
Alexander Vilkin, Moshe Leshno, Zohar Levi, Paul Rozen, Yaron Niv, Rachel Hazazi, Eran Maoz, Shlomo Birkenfeld, Amal Waked
Publikováno v:
Alimentary Pharmacology & Therapeutics. 29:906-917
Faecal occult blood tests (FOBT) are faulted by low sensitivity for advanced adenomatous polyps (AAP). Quantified, immunochemical, haemoglobin (Hb)-specific immunochemical FOBT (I-FOBT) measurements are now used for colorectal screening.To correlate
Autor:
Shlomo Birkenfeld, Amal Waked, Eran Maoz, Rachel Hazazi, Zohar Levi, S. Klang, Alex Vilkin, Nicky Lieberman, Paul Rozen, Yaron Niv
Publikováno v:
The American Journal of Gastroenterology. 104:933-938
We evaluated the effect of the use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDS), and anticoagulants on the performance of immunochemical fecal occult blood test (I-FOBT).A prospective, cross-sectional study of 1,221 ambulatory patients h
Publikováno v:
Digestive Diseases and Sciences. 54:848-852
Objectives This is the third survey that we have performed in the kibbutz population in Israel. The previous two surveys were 10 years apart, in 1987 and 1997, demonstrating an increase in Crohn’s disease prevalence. The aim of the present study wa
Autor:
Yaron Niv, Rachel Hazazi
Publikováno v:
Helicobacter. 13:56-61
Objective: Recurrence of Helicobacter pylori infection after eradication is rare in developed countries and more frequent in developing countries. Most recurrent cases are attributed to recrudescence (recolonization of the same strain within 12 month
Autor:
Eyal Gal, I. Kedar-Barnes, Eytan Mor, Zohar Levi, Rachel Hazazi, E. Hodak, Yaron Niv, J. Winkler
Publikováno v:
American Journal of Transplantation. 7:476-479
Little is known about the effects of immunosuppression on patients with hereditary nonpolyposis colorectal cancer (HNPCC). We describe a kidney transplant recipient with unrecognized Muir-Torre syndrome in whom the administration of a tacrolimus-base
Autor:
Rachel Hazazi, Yaron Niv, Shlomo Birkenfeld, Paul Rozen, Eran Maoz, Zohar Levi, Alex Vilkin, Doron Comaneshter
Publikováno v:
Cancer.
BACKGROUND: Quantified, human hemoglobin (Hb)-specific, immunochemical fecal occult blood test (IFOBT) measurements are now used for colorectal cancer (CRC) screening. The objective was to evaluate sensitivity and specificity for CRC and advanced ade
Publikováno v:
Journal of clinical gastroenterology. 43(8)
This is the third survey we perform in the kibbutz population of Israel. The previous 2 surveys were 10 years apart, in 1987 and 1997, demonstrating an increase in ulcerative colitis (UC) prevalence. The aim of the present study was to confirm the tr
Autor:
Paul, Rozen, Zohar, Levi, Rachel, Hazazi, Inbal, Barnes-Kedar, Ziona, Samuel, Alex, Vilkin, Yaron, Niv
Publikováno v:
The Israel Medical Association journal : IMAJ. 10(10)
Dedicated, organ-specific screening clinics have been shown to significantly reduce cancer morbidity and mortality.To establish a dedicated clinic for Clalit Health Service patients at high risk for hereditary gastrointestinal cancer and to provide t